Article Text
Editorial
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
Abstract
A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases
- BNP, brain natriuretic peptide
- CHF, chronic heart failure
- NO, nitric oxide
- XO, xanthine oxidase
- allopurinol
- heart failure
- xanthine oxidoreductase
Statistics from Altmetric.com
Linked Articles
- Miscellanea